Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

@article{Sorror2005HematopoieticCT,
  title={Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.},
  author={M. Sorror and M. Maris and R. Storb and F. Baron and B. Sandmaier and D. Maloney and B. Storer},
  journal={Blood},
  year={2005},
  volume={106},
  pages={2912-2919}
}
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting outcomes in patients undergoing allogeneic hematopoietic cell transplantation (HCT). However, the sample size of patients with scores of 1 or more, captured by the CCI, did not exceed 35%. Further, some comorbidities were rarely found among patients who underwent HCT. Therefore, the current study was designed to (1) better define previously identified comorbidities using pretransplant laboratory data, (2… Expand
Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia
TLDR
The study results suggest that patients with CN‐AML in CR1 who are eligible for HSCT may have a survival benefit from HSCT, especially the allogeneic HSCT. Expand
Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
  • P. Barba, J. Piñana, +7 authors J. Sierra
  • Medicine
  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2010
TLDR
A single-center study suggests that the flexible HCT-CI is a good predictor of 2-year NRM and survival after an allo-RIC and the Charlson Comorbidity Index was the best predictor for non-relapse mortality. Expand
Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study.
TLDR
It is revealed that AHSCT seemed to be acceptable in patients over 70 years of age with non-Hodgkin's lymphoma, and patient age is not a limiting factor if clinical condition is adequate. Expand
Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.
  • P. Barba, R. Martino, +10 authors D. Valcárcel
  • Medicine
  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2014
TLDR
The combination of HCT-CI and the EBMT score is feasible and might contribute to a better identification of high-risk patients, improving selection of best allogeneic HCT candidates. Expand
Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients.
TLDR
Assessment of comorbidities at diagnosis in MDS patients may improve the ability of therapeutic decisions and the presence of cardiac, liver, renal, pulmonary diseases and solid tumours was found to independently affect the risk of death in a multivariable Cox regression analysis. Expand
Myeloablative hematopoietic stem cell transplantation for myelodysplastic syndrome in patients younger than 55 years: impact of comorbidity and disease burden on the long‐term outcome
TLDR
It is suggested that comorbidity and the tumor burden at the time of transplantation may be useful variables for predicting the outcome in MDS patients receiving myeloablative HCT. Expand
Pre-Transplant Predictors and Post-Transplant Sequels of Acute Kidney Injury After Allogeneic Stem Cell Transplantation.
TLDR
The strategy to prevent the occurrence of life-threatening severe AKI in patients with a high HCT-CI score would be imperative to improve their survival after allogeneic SCT, and it was found that high H CT-CI scores, particularly ≥3, were the most important pre-transplant predictor of severeAKI. Expand
Assessment and Impact of Comorbidity in Older Adults with Cancer
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
  • A. Artz, A. Wickrema, +8 authors K. V. van Besien
  • Medicine
  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2008
TLDR
It is suggested that preconditioning CRP holds promise for enhancing estimates of transplantation tolerance, and after adjustment for disease status, comorbidity, performance status, and age, elevated CRP concentration remained predictive of NRM. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 68 REFERENCES
Graft-versus-host disease
TLDR
The full therapeutic potential of allogeneic haematopoietic SCT will not be realized until approaches to minimize GVHD, while maintaining the positive contributions of donor T cells are developed. Expand
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
  • F. Baron, M. Maris, +9 authors R. Storb
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2005
TLDR
New approaches aimed at reducing the incidence of grade 2 to 4 acute GVHD might improve survival after allogeneic HCT after nonmyeloablative conditioning. Expand
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
  • M. Sorror, M. Maris, +17 authors D. Maloney
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2005
TLDR
CLL is susceptible to graft-versus-leukemia effects, and allogeneic HCT after nonmyeloablative conditioning might prolong median survival for patients with advanced CLL. Expand
NUMBER 8 For personal use only
  • NUMBER 8 For personal use only
  • 2005
Prognostic relevance of ‘early‐onset’ graft‐versus‐host disease following non‐myeloablative haematopoietic cell transplantation
TLDR
Patients with early‐onset GVHD after non‐myeloablative HCT from HLA‐identical related donors might benefit from intensified primary immunosuppressive treatment. Expand
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.
TLDR
Allogeneic HCT after nonmyeloablative conditioning with fludarabine and 2 Gy total body irradiation is a promising salvage strategy for patients with relapsed and refractory mantle cell lymphoma, and the high response and low relapse rates suggest that mantlecell lymphoma is susceptible to graft-versus-tumor responses. Expand
Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization.
TLDR
CCI is a strong predictor of mortality in incident HD patients as has also been indicated in PD patients; CCI correlates with phase angle calculated from Bioelectrical Impedance Analysis and this last factor can be used in the following examinations; several days of hospitalization are a very important determinant in the survival in hemodialysis patients. Expand
Charlson Index Comorbidity Adjustment for Ischemic Stroke Outcome Studies
TLDR
Data support the validity of the Charlson Index as a measure of comorbidity for use in ischemic stroke outcome studies. Expand
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
TLDR
Even though nonablative patients had significantly higher pretransplantation comorbidity scores, were older, and had more often failed preceding ablative transplantations and cytotoxic therapies, they experienced fewer grades III to IV toxicities than ablative patients. Expand
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial
TLDR
It is shown that elderly patients have a higher TRM following an RIC protocol, however, age by itself should not preclude these RIC transplants, since TRM appears to be unacceptably high only in the presence of additional adverse factors. Expand
...
1
2
3
4
5
...